Patient-centred interventions significantly improve asthma outcomes by reducing exacerbations, improving asthma control and thus, contributing to an overall improved quality of life, suggests a recent study published in The New England Journal of Medicine. The observational trial by a team led by Dr Elliot Israel at the Brigham’s Pulmonary and Critical Care Division, Brigham and Women’s Hospital, found that the new intervention decreased the risk of severe asthma exacerbations by 15 percent (0.13 exacerbations per patient per year) and reduced asthma symptoms and days of impairment in AA/B and H/L patients with moderate-to-severe asthma. The researchers said that they analysed 1,201 adults with moderate-to-severe asthma who were randomised to receive one-time instruction for using ICS as needed to find that the cost-effective intervention provided a patient-centred way to reduce severe asthma exacerbations. 

Source: eurekalert